Michael Megna
Comptroller/Controller/Auditor en KINIKSA PHARMACEUTICALS, LTD. .
Fortuna: 375 586 $ al 30/04/2024
Cargos activos de Michael Megna
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
KINIKSA PHARMACEUTICALS, LTD. | Comptroller/Controller/Auditor | 04/02/2020 | - |
Director Financiero/CFO | - | 17/12/2020 | |
Corporate Officer/Principal | 01/07/2018 | 04/02/2020 |
Historial de carrera de Michael Megna
Antiguos cargos conocidos de Michael Megna.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
BioSphere Medical, Inc.
BioSphere Medical, Inc. Medical SpecialtiesHealth Technology BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA. | Comptroller/Controller/Auditor | 01/09/2004 | 01/11/2010 |
LFB USA, Inc.
LFB USA, Inc. Pharmaceuticals: MajorHealth Technology LFB USA, Inc. is a pharmaceutical company based in Framingham, MA. The company develops and provides pharmaceutical bioproducts through innovative technologies for patients with serious diseases. LFB USA is committed to improving people's lives by overcoming barriers through purposeful science. The company offers a robust set of services that powers its own pipeline to its partners. LFB USA's rpro technology is revolutionizing recombinant protein production for a new generation of therapeutics. The company is ultimately controlled by the Government of France. Jose Antonio Moreno Toscano has been the CEO of the company since 2018. | Comptroller/Controller/Auditor | - | - |
Formación de Michael Megna.
Siena College | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 5 |
Operativa
Comptroller/Controller/Auditor | 3 |
Director of Finance/CFO | 1 |
Corporate Officer/Principal | 1 |
Sectorial
Health Technology | 4 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
KINIKSA PHARMACEUTICALS, LTD. | Health Technology |
Empresas privadas | 2 |
---|---|
BioSphere Medical, Inc.
BioSphere Medical, Inc. Medical SpecialtiesHealth Technology BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA. | Health Technology |
LFB USA, Inc.
LFB USA, Inc. Pharmaceuticals: MajorHealth Technology LFB USA, Inc. is a pharmaceutical company based in Framingham, MA. The company develops and provides pharmaceutical bioproducts through innovative technologies for patients with serious diseases. LFB USA is committed to improving people's lives by overcoming barriers through purposeful science. The company offers a robust set of services that powers its own pipeline to its partners. LFB USA's rpro technology is revolutionizing recombinant protein production for a new generation of therapeutics. The company is ultimately controlled by the Government of France. Jose Antonio Moreno Toscano has been the CEO of the company since 2018. | Health Technology |
- Bolsa de valores
- Insiders
- Michael Megna
- Experiencia